Serina Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-7.8M | $-7.8M | $20.0K | $909.0K |
| FY2021 | $-7.9M | $-7.9M | — | $999.0K |
| FY2022 | $-5.9M | $-5.9M | — | $760.0K |
| FY2023 | $-2.5M | $-3.0M | $504.0K | $25.0K |
| FY2024 | $-17.1M | $-17.2M | $22.0K | $2.6M |